Recent News

Chimpanzee Adenovirus Vector Ebola Vaccine

In August 2014, the World Health Organization declared the epidemic of Ebola virus disease (EVD) in West Africa to be a public health emergency of international concern. This was the first time in more than 20 outbreaks since EVD was identified in 1976 that such a declaration had been made. The…
  • 1

    Bausch, Daniel G., . . (2017) One Step Closer to an Ebola Virus Vaccine. New England Journal of Medicine 376:10, 984-985.
    Free Full Text

  • 2

    I. V. Dolzhikova, O. V. Zubkova, A. I. Tukhvatulin, A. S. Dzharullaeva, N. M. Tukhvatulina, D. V. Shcheblyakov, M. M. Shmarov, E. A. Tokarskaya, Y. V. Simakova, D. A. Egorova, D. N. Scherbinin, I. L. Tutykhina, A. A. Lysenko, A. V. Kostarnoy, P. G. Gancheva, T. A. Ozharovskaya, B. V. Belugin, L. V. Kolobukhina, V. B. Pantyukhov, S. I. Syromyatnikova, I. V. Shatokhina, T. V. Sizikova, I. G. Rumyantseva, A. F. Andrus, N. V. Boyarskaya, A. N. Voytyuk, V. F. Babira, S. V. Volchikhina, D. A. Kutaev, A. N. Bel'skih, K. V. Zhdanov, S. M. Zakharenko, S. V. Borisevich, D. Y. Logunov, B. S. Naroditsky, A. L. Gintsburg. . (2017) Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia. Human Vaccines & Immunotherapeutics, 1-8.
    CrossRef

  • 3

    D. Wichmann, B. Kreuels, S. Schmiedel, S. Kluge. . (2017) Intensivmedizinische Behandlung eines Patienten mit Ebola-Virusinfektion in Deutschland. Medizinische Klinik - Intensivmedizin und Notfallmedizin 112:1, 38-41.
    CrossRef

  • 4

    Rohan Keshwara, Reed F. Johnson, Matthias J. Schnell. . (2017) Toward an Effective Ebola Virus Vaccine. Annual Review of Medicine 68:1, 371-386.
    CrossRef

  • 5

    Yuxiao Wang, Jingxin Li, Yuemei Hu, Qi Liang, Mingwei Wei, Fengcai Zhu. . (2017) Ebola vaccines in clinical trial: The promising candidates. Human Vaccines & Immunotherapeutics 13:1, 153-168.
    CrossRef

  • 6

    Stephanie Fresnay, Monica A. McArthur, Laurence Magder, Thomas C. Darton, Claire Jones, Claire S. Waddington, Christoph J. Blohmke, Brian Angus, Myron M. Levine, Andrew J. Pollard, Marcelo B. Sztein. . (2016) Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans. Journal of Translational Medicine 14:1.
    CrossRef

  • 7

    Pauline Vetter, Julie-Anne Dayer, Manuel Schibler, Benedetta Allegranzi, Donal Brown, Alexandra Calmy, Derek Christie, Sergey Eremin, Olivier Hagon, David Henderson, Anne Iten, Edward Kelley, Frederick Marais, Babacar Ndoye, Jérôme Pugin, Hugues Robert-Nicoud, Esther Sterk, Michael Tapper, Claire-Anne Siegrist, Laurent Kaiser, Didier Pittet. . (2016) The 2014–2015 Ebola outbreak in West Africa: Hands On. Antimicrobial Resistance & Infection Control 5:1.
    CrossRef

  • 8

    Sara Viksmoen Watle, Gunnstein Norheim, John-Arne Røttingen. . (2016) Ebola vaccines – Where are we?. Human Vaccines & Immunotherapeutics 12:10, 2700-2703.
    CrossRef

  • 9

    Yuanwu Liu, Jing Sun, Hongwen Zhang, Mingming Wang, George Fu Gao, Xiangdong Li. . (2016) Ebola virus encodes a miR-155 analog to regulate importin-α5 expression. Cellular and Molecular Life Sciences 73:19, 3733-3744.
    CrossRef

  • 10

    M. Lachâtre, Y. Yazdanpanah. . (2016) Maladie à virus Ebola : actualités thérapeutiques. Journal des Anti-infectieux 18:3, 117-125.
    CrossRef

  • 11

    Chao Zhang, Dongming Zhou. . (2016) Adenoviral vector-based strategies against infectious disease and cancer. Human Vaccines & Immunotherapeutics 12:8, 2064-2074.
    CrossRef

  • 12

    Fernando de la Calle-Prieto, Marta Arsuaga-Vicente, Marta Mora-Rillo, Francisco Arnalich-Fernandez, Jose Ramon Arribas. . (2016) Enfermedad por virus ebola: actualización. Enfermedades Infecciosas y Microbiología Clínica 34:7, 452-460.
    CrossRef

  • 13

    Katie J Ewer, Teresa Lambe, Christine S Rollier, Alexandra J Spencer, Adrian VS Hill, Lucy Dorrell. . (2016) Viral vectors as vaccine platforms: from immunogenicity to impact. Current Opinion in Immunology 41, 47-54.
    CrossRef

  • 14

    (2016) Novel bat adenoviruses with an extremely large E3 gene. Journal of General Virology 97:7, 1625-1635.
    CrossRef

  • 15

    Bridgette Jeanne Billioux, Bryan Smith, Avindra Nath. . (2016) Neurological Complications of Ebola Virus Infection. Neurotherapeutics 13:3, 461-470.
    CrossRef

  • 16

    Changping Xu, Hualei Wang, Hongli Jin, Na Feng, Xuexing Zheng, Zengguo Cao, Ling Li, Jianzhong Wang, Feihu Yan, Lina Wang, Hang Chi, Weiwei Gai, Chong Wang, Yongkun Zhao, Yan Feng, Tiecheng Wang, Yuwei Gao, Yiyu Lu, Songtao Yang, Xianzhu Xia. . (2016) Visual detection of Ebola virus using reverse transcription loop-mediated isothermal amplification combined with nucleic acid strip detection. Archives of Virology 161:5, 1125-1133.
    CrossRef

  • 17

    Ewer, Katie, Rampling, Tommy, Venkatraman, Navin, Bowyer, Georgina, Wright, Danny, Lambe, Teresa, Imoukhuede, Egeruan B., Payne, Ruth, Fehling, Sarah Katharina, Strecker, Thomas, Biedenkopf, Nadine, Krähling, Verena, Tully, Claire M., Edwards, Nick J., Bentley, Emma M., Samuel, Dhanraj, Labbé, Geneviève, Jin, Jing, Gibani, Malick, Minhinnick, Alice, Wilkie, Morven, Poulton, Ian, Lella, Natalie, Roberts, Rachel, Hartnell, Felicity, Bliss, Carly, Sierra-Davidson, Kailan, Powlson, Jonathan, Berrie, Eleanor, Tedder, Richard, Roman, Francois, De Ryck, Iris, Nicosia, Alfredo, Sullivan, Nancy J., Stanley, Daphne A., Mbaya, Olivier T., Ledgerwood, Julie E., Schwartz, Richard M., Siani, Loredana, Colloca, Stefano, Folgori, Antonella, Di Marco, Stefania, Cortese, Riccardo, Wright, Edward, Becker, Stephan, Graham, Barney S., Koup, Richard A., Levine, Myron M., Volkmann, Ariane, Chaplin, Paul, Pollard, Andrew J., Draper, Simon J., Ballou, W. Ripley, Lawrie, Alison, Gilbert, Sarah C., Hill, Adrian V.S., . . (2016) A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA. New England Journal of Medicine 374:17, 1635-1646.
    Free Full Text

  • 18

    Robert A. Lever, Christopher J. M. Whitty. . (2016) Ebola virus disease: emergence, outbreak and future directions. British Medical Bulletin 117:1, 95-106.
    CrossRef

  • 19

    Stephen B Kennedy, James D Neaton, H Clifford Lane, Mark WS Kieh, Moses BF Massaquoi, Nancy A Touchette, Martha C Nason, Dean A Follmann, Fatorma K Boley, Melvin P Johnson, Gregg Larson, Francis N Kateh, Tolbert G Nyenswah. . (2016) Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges. Clinical Trials 13:1, 49-56.
    CrossRef

  • 20

    Martha Nason. . (2016) Statistics and logistics: Design of Ebola vaccine trials in West Africa. Clinical Trials 13:1, 87-91.
    CrossRef

  • 21

    Joanna Luczkowiak, José R. Arribas, Sara Gómez, Víctor Jiménez-Yuste, Fernando de la Calle, Aurora Viejo, Rafael Delgado. . (2016) Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus. Virus Research 213, 224-229.
    CrossRef

  • 22

    Teresa Lambe, Tommy Rampling, Dhan Samuel, Georgina Bowyer, Katie J. Ewer, Navin Venkatraman, Matthew Edmans, Steve Dicks, Adrian V. S. Hill, Richard S. Tedder, Sarah C. Gilbert. . (2016) Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid. Open Forum Infectious Diseases 3:1, ofw031.
    CrossRef

  • 23

    Michael Osterholm, Kristine Moore, Julie Ostrowsky, Kathleen Kimball-Baker, Jeremy Farrar. . (2016) The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats. The Lancet Infectious Diseases 16:1, e1-e9.
    CrossRef

  • 24

    Rebecca Reece, Michael A. Smit, Timothy P. Flanigan. . 2016. Ebola Virus. Encyclopedia of Immunobiology, 355-362.
    CrossRef

  • 25

    Myron M. Levine, Wilbur H. Chen. . 2016. How are Vaccines Assessed in Clinical Trials?. The Vaccine Book, 97-119.
    CrossRef

  • 26

    Gurpreet Singh, Arbind Kumar, Kashmir Singh, Jagdeep Kaur. . (2016) Ebola virus: an introduction and its pathology. Reviews in Medical Virology 26:1, 49-56.
    CrossRef

  • 27

    Yasser A. Aldhamen, Andrea Amalfitano. . 2016. Methods to Mitigate Immune Responses to Adenoviral Vectors. Adenoviral Vectors for Gene Therapy, 391-422.
    CrossRef

  • 28

    Milagritos D Tapia, Samba O Sow, Kirsten E Lyke, Fadima Cheick Haidara, Fatoumata Diallo, Moussa Doumbia, Awa Traore, Flanon Coulibaly, Mamoudou Kodio, Uma Onwuchekwa, Marcelo B Sztein, Rezwanul Wahid, James D Campbell, Marie-Paule Kieny, Vasee Moorthy, Egeruan B Imoukhuede, Tommy Rampling, Francois Roman, Iris De Ryck, Abbie R Bellamy, Len Dally, Olivier Tshiani Mbaya, Aurélie Ploquin, Yan Zhou, Daphne A Stanley, Robert Bailer, Richard A Koup, Mario Roederer, Julie Ledgerwood, Adrian V S Hill, W Ripley Ballou, Nancy Sullivan, Barney Graham, Myron M Levine. . (2016) Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial. The Lancet Infectious Diseases 16:1, 31-42.
    CrossRef

  • 29

    Guojing Wang, Rui Zhang, Yanxi Han, Le Chang, Dong Zhang, Lei Zhang, Xin Yang, Chao Liu, Jiansheng Ding, Kuo Zhang, Guigao Lin, Xie Jiehong, Jinming Li. . (2015) The evaluation of 7 commercial real-time PCR kits for Zaire ebolavirus using virus-like particle–encapsulated EBOV RNA. Diagnostic Microbiology and Infectious Disease 83:4, 355-358.
    CrossRef

  • 30

    CHANDRA SHEKHAR. . (2015) Ebola virus disease with special reference to epidemiology and management. VETERINARY SCIENCE RESEARCH JOURNAL 6:2, 103-112.
    CrossRef

  • 31

    Julie E Ledgerwood. . (2015) Use of low dose rVSV-ZEBOV: safety issues in a Swiss cohort. The Lancet Infectious Diseases 15:10, 1117-1119.
    CrossRef

  • 32

    Ingrid L Scully, Kena Swanson, Luke Green, Kathrin U Jansen, Annaliesa S Anderson. . (2015) Anti-infective vaccination in the 21st century—new horizons for personal and public health. Current Opinion in Microbiology 27, 96-102.
    CrossRef

  • 33

    Scott Anthony, Steven Bradfute. . (2015) Filoviruses: One of These Things is (not) Like the Other. Viruses 7:10, 5172-5190.
    CrossRef

  • 34

    Angela Huttner, Julie-Anne Dayer, Sabine Yerly, Christophe Combescure, Floriane Auderset, Jules Desmeules, Markus Eickmann, Axel Finckh, Ana Rita Goncalves, Jay W Hooper, Gürkan Kaya, Verena Krähling, Steve Kwilas, Barbara Lemaître, Alain Matthey, Peter Silvera, Stephan Becker, Patricia E Fast, Vasee Moorthy, Marie Paule Kieny, Laurent Kaiser, Claire-Anne Siegrist. . (2015) The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. The Lancet Infectious Diseases 15:10, 1156-1166.
    CrossRef

  • 35

    Thomas W. Geisbert, James E. Strong, Heinz Feldmann. . (2015) Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection: Table 1.. Journal of Infectious Diseases 212:suppl 2, S91-S97.
    CrossRef

  • 36

    A. Mirazimi. . (2015) Ebola virus disease: societal challenges and new treatments. Journal of Internal Medicine 278:3, 227-237.
    CrossRef

  • 37

    Annick Hens, Valerie Asselman, Ilse De Coster, Pierre Van Damme. . (2015) Nieuwe vaccins. Bijblijven 31:7, 535-554.
    CrossRef

  • 38

    Jin Huk Choi, Stephen C. Schafer, Alexander N. Freiberg, Maria A. Croyle. . (2015) Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine. Molecular Pharmaceutics 12:8, 2697-2711.
    CrossRef

  • 39

    Ana Maria Henao-Restrepo, Ira M Longini, Matthias Egger, Natalie E Dean, W John Edmunds, Anton Camacho, Miles W Carroll, Moussa Doumbia, Bertrand Draguez, Sophie Duraffour, Godwin Enwere, Rebecca Grais, Stephan Gunther, Stefanie Hossmann, Mandy Kader Kondé, Souleymane Kone, Eeva Kuisma, Myron M Levine, Sema Mandal, Gunnstein Norheim, Ximena Riveros, Aboubacar Soumah, Sven Trelle, Andrea S Vicari, Conall H Watson, Sakoba Kéïta, Marie Paule Kieny, John-Arne Røttingen. . (2015) Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. The Lancet 386:9996, 857-866.
    CrossRef

  • 40

    Yan Zhou, Nancy J Sullivan. . (2015) Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine. Current Opinion in Immunology 35, 131-136.
    CrossRef

  • 41

    Allison Groseth, Markus Eickmann, Hideki Ebihara, Stephan Becker, Thomas Hoenen. . 2015. Filoviruses: Ebola, Marburg and Disease. eLS, 1-13.
    CrossRef

  • 42

    Života Selaković, Veronica Soloveva, Dima N. Gharaibeh, Jay Wells, Sandra Šegan, Rekha G. Panchal, Bogdan A. Šolaja. . (2015) Anti-Ebola Activity of Diazachrysene Small Molecules. ACS Infectious Diseases 1:6, 264-271.
    CrossRef

  • 43

    Feng-Cai Zhu, Li-Hua Hou, Jing-Xin Li, Shi-Po Wu, Pei Liu, Gui-Rong Zhang, Yue-Mei Hu, Fan-Yue Meng, Jun-Jie Xu, Rong Tang, Jin-Long Zhang, Wen-Juan Wang, Lei Duan, Kai Chu, Qi Liang, Jia-Lei Hu, Li Luo, Tao Zhu, Jun-Zhi Wang, Wei Chen. . (2015) Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet 385:9984, 2272-2279.
    CrossRef

  • 44

    Andrea Marzi, Darryl Falzarano. . (2015) An updated Ebola vaccine: immunogenic, but will it protect?. The Lancet 385:9984, 2229-2230.
    CrossRef

  • 45

    Gerardo Chowell, Cécile Viboud. . (2015) Ebola vaccine trials: a race against the clock. The Lancet Infectious Diseases 15:6, 624-626.
    CrossRef

  • 46

    Andrea Rivera, Ilhem Messaoudi. . (2015) Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes. ACS Infectious Diseases 1:5, 186-197.
    CrossRef

  • 47

    Giovanni Rezza. . (2015) A vaccine against Ebola: Problems and opportunities. Human Vaccines & Immunotherapeutics 11:5, 1258-1260.
    CrossRef

  • 48

    J. Reina, A. Iñigo. . (2015) Situación actual de las vacunas frente al virus del Ébola. Vacunas 16:2, 56-64.
    CrossRef

  • 49

    J. Otter. . (2015) Journal Roundup: Ebola, antibiotic use and abuse, and the usual suspects. Journal of Hospital Infection 90:1, 85-86.
    CrossRef

  • 50

    Saranya Sridhar. . (2015) Ebola and Marburg vaccines for Africa: one step closer. The Lancet 385:9977, 1491-1493.
    CrossRef

  • 51

    Anna Roca, Muhammed O. Afolabi, Yauba Saidu, Beate Kampmann. . (2015) Ebola: A holistic approach is required to achieve effective management and control. Journal of Allergy and Clinical Immunology 135:4, 856-867.
    CrossRef

  • 52

    Hannah Kibuuka, Nina M Berkowitz, Monica Millard, Mary E Enama, Allan Tindikahwa, Arthur B Sekiziyivu, Pamela Costner, Sandra Sitar, Deline Glover, Zonghui Hu, Gyan Joshi, Daphne Stanley, Meghan Kunchai, Leigh Anne Eller, Robert T Bailer, Richard A Koup, Gary J Nabel, John R Mascola, Nancy J Sullivan, Barney S Graham, Mario Roederer, Nelson L Michael, Merlin L Robb, Julie E Ledgerwood. . (2015) Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. The Lancet 385:9977, 1545-1554.
    CrossRef

  • 53

    William B. Millard. . (2015) Channeling, High-Level Biocontainment and Research. Annals of Emergency Medicine 65:2, A15-A22.
    CrossRef

  • 54

    Bruce Y Lee, William J Moss, Lois Privor-Dumm, Dagna O Constenla, Maria D Knoll, Katherine L O'Brien. . (2015) Is the world ready for an Ebola vaccine?. The Lancet 385:9964, 203-204.
    CrossRef

  • Original Link...


    Tags: infectiology, MEDICINE
    0 Volde
    Report        

    Read On: